Skip to main content
Michael Chuong, MD, Radiation Oncology, Miami, FL, Baptist Hospital of Miami

MichaelChuongMDFACRO

Radiation Oncology Miami, FL

Gastrointestinal Cancer

Medical Director, Dept of Radiation Oncology

Overview of Dr. Chuong

Dr. Michael Chuong is a radiation oncologist in Miami, FL and is affiliated with Baptist Hospital of Miami. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 12 years. He is one of 23 doctors at Baptist Hospital of Miami who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Radiation Oncology, 2009 - 2013
  • University of South Florida Morsani
    University of South Florida MorsaniInternship, Internal Medicine, 2008 - 2009
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 2008, MD
  • Brandeis University
    Brandeis UniversityBA, Biology, Cum Laude, 2000 - 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2026
  • MD State Medical License
    MD State Medical License 2013 - 2016
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Merit Award American Society of Clinical Medicine Conquer Cancer Foundation, 2013
  • Roentgen Resident/Fellow Research Award RSNA Research and Education Foundation, 2012
  • Moffitt Cancer Center Research Symposium Clinical Research Award 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma  
    Mellon E, Hoffe S, Springett G, Frakes J, Hodul P, Malafa M, Strom T, Chuong M, Shridhar R, Acta Oncologica, 1/3/2015
  • Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy  
    D'Emic N, Engelman A, Molitoris J, Hanlon A, Sharma NK, Moeslein FM, Chuong MD, Journal of Gastrointestinal Oncology, 1/1/2015
  • Anterior-oriented beam arrangements with daily in vivo range verification for proton therapy in prostate cancer: Rectal toxicity rates  
    Polf JC, Chuong MD, Zhang B, Mehta M, International Journal of Particle Therapy, 1/1/2015
  • Join now to see all

Books/Book Chapters

Lectures

  • Gastrointestinal Cancers 
    Baltimore, MD - 1/8/2015
  • Hepatocellular carcinoma and pancreatic cancer 
    UMMC, 2014, 2015 - 1/1/2015
  • Is pencil beam scanning dosimetrically advantageous compared to passively scattered proton therapy for unresectable pancreatic cancer? 
    San Diego, CA - 1/1/2015
  • Join now to see all

Other

  • Challenging Liver Cases (debate panel member) 
    Chuong MD, Particle Therapy Co-Operative Group Annual Meeting
    San Diego, CA - 1/1/2015

Press Mentions

  • MRIdian Clinical and Research Experience Featured in Nearly 40 Abstracts at ESTRO 2022, the Leading European Radiation Oncology Meeting
    MRIdian Clinical and Research Experience Featured in Nearly 40 Abstracts at ESTRO 2022, the Leading European Radiation Oncology MeetingMay 6th, 2022
  • About 40 Abstracts Exhibited at the MRIDian Clinical and Research Experience Astro 2022, the Leading European Radiation Oncology Meeting
    About 40 Abstracts Exhibited at the MRIDian Clinical and Research Experience Astro 2022, the Leading European Radiation Oncology MeetingMay 6th, 2022
  • How MRI-Guided Radiation Therapy Is Changing the Paradigm in Pancreatic Cancer
    How MRI-Guided Radiation Therapy Is Changing the Paradigm in Pancreatic CancerNovember 14th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations